OSR Health OSRH
NASDAQ OSRH
$0.20 +0.00 (+0.00%)
At close: Sep 8, 2026 · 4:00 PM EDT

OSR Health (OSRH) EBT Margin (2024 - 2026)

OSR Health's (OSRH) quarterly EBT Margin came in at 457.3% in Q2 2026, up 286.0% year-over-year from 118.47% in Q2 2025, and up 43.52% quarter-over-quarter from 809.72% in Q1 2026.

Analysis

OSR Health (OSRH) EBT Margin (2024 - 2026) Analysis & Trends

OSR Health has disclosed EBT Margin across 3 years of filings, most recently posting 457.3% for Q2 2026.

  • In Q2 2026, EBT Margin rose 286.0% year-over-year to 457.3%; the TTM figure through Jun 2026 stood at 974.9% (down 37231.0% YoY), while the FY2025 annual figure was 994.16%, down 65729.0% from the prior year.
  • EBT Margin came in at 457.3% for Q2 2026 at OSR Health, up from 809.72% in the prior quarter.
  • In the past five years, EBT Margin ranged from a high of 195.59% in Q4 2024 to a low of 2040.69% in Q4 2025.
  • Average EBT Margin over 3 years is 733.73%, with a median of 458.73% recorded in 2025.
  • Year-over-year, EBT Margin tumbled 184510 bps in 2025 and jumped 68684 bps in 2026.
  • Over 3 years, EBT Margin stood at 195.59% in 2024, then plunged by 943 bps to 2040.69% in 2025, then jumped by 78 bps to 457.3% in 2026.
  • Per Business Quant data, the three most recent EBT Margin figures were 457.3% in Q2 2026, 809.72% in Q1 2026, and 2040.69% in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Amgen 211.73 Bn 197.74 Bn 7.24 Bn 27.53%
2 Gilead Sciences 180.92 Bn 177.74 Bn 6.22 Bn -131.41%
3 Vertex Pharmaceuticals 132.16 Bn 124.30 Bn 2.84 Bn 41.75%
4 Regeneron Pharmaceuticals 82.89 Bn 74.90 Bn 3.93 Bn 35.61%
5 Argenx Se 61.41 Bn 56.23 Bn 1.37 Bn 35.78%
6 Moderna 53.99 Bn 48.85 Bn 52.00 Mn -528.97%
7 Alnylam Pharmaceuticals 34.48 Bn 31.18 Bn 992.69 Mn 13.77%
8 Biogen 31.15 Bn 29.86 Bn 1.96 Bn 4.84%
9 Roivant Sciences 30.05 Bn 30.05 Bn 1.16 Mn -20,427.46%
10 OSR Health 6.59 Mn 4.94 Mn 86,605.00 -457.30%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -457.30%
Mar 31, 2026 -809.72%
Dec 31, 2025 -2,040.69%
Sep 30, 2025 -715.23%
Jun 30, 2025 -460.16%
Mar 31, 2025 -1,496.55%
Dec 31, 2024 -195.59%
Sep 30, 2024 -424.80%
Jun 30, 2024 -368.68%
Mar 31, 2024 -368.63%